Prostatic HyperplasiaNCT06995963
Impact of TURP on Quality of Life in Patients With Benign Prostatic Hyperplasia: A Retrospective Study
An observational study of Prostatic Hyperplasia and Prostatectomy, run by Centre Hospitalier de Gonesse at 1 site in France.
Trial summary
This study looks at how a common surgery called TURP (Transurethral Resection of the Prostate) affects the quality of life in men with benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Prostatic Hyperplasia, Prostatectomy, Transurethral Resection of Prostate
- How many people
- 30 participants
- Where
- 1 siteFrance
- Study dates
- 1 Feb 2025to 1 Apr 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Child, Adult, Older adult
Study population: The study population consists of adult male patients diagnosed with benign prostatic hyperplasia (BPH) who underwent transurethral resection of the prostate (TURP) at a single medical center. Participants will be selected retrospectively from medical records of patients treated between February and April. All included patients must have urinary symptoms related to prostatic obstruction and complete pre- and post-operative data available, including IPSS scores.
Who may be able to join
- Male patients with urinary symptoms related to prostatic obstruction
- Patients who underwent transurethral resection of the prostate (TURP)
- Availability of pre- and post-operative data (including IPSS)
Who cannot join
- Patients with urinary symptoms not related to prostatic obstruction
- Patients who did not undergo TURP
- Incomplete or missing clinical data required for analysis
Trial locations and contacts
1 site in 1 country.
About this study
This study looks at how a common surgery called TURP (Transurethral Resection of the Prostate) affects the quality of life in men with benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate. By reviewing past medical records of patients who had this surgery, researchers will evaluate how urinary symptoms and overall well-being changed after the procedure.
- Conditions
- Prostatic Hyperplasia, Prostatectomy, Transurethral Resection of Prostate, Quality of Life, Urinary Tract Symptoms, Treatment Outcome
- Medical subject headings
- Prostatic Hyperplasia
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in urinary symptoms after TURP, measured by the IPSS
Measured: From baseline (pre-surgery) to 1-3 months post-surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 May 2025
- Study start1 Feb 2025
- Primary completion1 Apr 2025
- Study completion1 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Prostatic HyperplasiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Gonesse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06995963
- Sponsor's protocol ID
- 0099_UROLOGIE
- Status last verified
- May 2025
- First submitted
- 21 May 2025
- Last updated
- 30 May 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of TURP on Quality of Life in Patients With Benign Prostatic Hyperplasia: A Retrospective Study
- ClinicalTrials.gov ID
- NCT06995963
- Acronym / sponsor ID
- 0099_UROLOGIE
- Conditions
- Prostatic Hyperplasia, Prostatectomy, Transurethral Resection of Prostate, Quality of Life, Urinary Tract Symptoms, Treatment Outcome
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Centre Hospitalier de GonesseUniversity, hospital or other
- Study start
- 1 Feb 2025 (actual)
- Primary completion
- 1 Apr 2025 (actual)
- Study completion
- 1 Apr 2025 (actual)
- First posted
- 30 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study looks at how a common surgery called TURP (Transurethral Resection of the Prostate) affects the quality of life in men with benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate. By reviewing past medical records of patients who had this surgery, researchers will evaluate how urinary symptoms and overall well-being changed after the procedure.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Age groups
- Child, Adult, Older adult
- Study population
- The study population consists of adult male patients diagnosed with benign prostatic hyperplasia (BPH) who underwent transurethral resection of the prostate (TURP) at a single medical center. Participants will be selected retrospectively from medical records of patients treated between February and April. All included patients must have urinary symptoms related to prostatic obstruction and complete pre- and post-operative data available, including IPSS scores.
Key inclusion criteria (3 listed)
- Male patients with urinary symptoms related to prostatic obstruction
- Patients who underwent transurethral resection of the prostate (TURP)
- Availability of pre- and post-operative data (including IPSS)
Key exclusion criteria (3 listed)
- Patients with urinary symptoms not related to prostatic obstruction
- Patients who did not undergo TURP
- Incomplete or missing clinical data required for analysis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Change in urinary symptoms after TURP, measured by the IPSS
Time frame: From baseline (pre-surgery) to 1-3 months post-surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 May 2025.
Related trials for Prostatic Hyperplasia
Recruiting
Clinical Study on Prostate Thermal Vapor Ablation Guided by MRI/TRUS Fusion Imaging
Benign Prostatic Hyperplasia (BPH)
Active, not recruitingPhase 4
Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic Obstruction
BPH (Benign Prostatic Hyperplasia)
RecruitingObservational study
ProVIDE Studies Post Exit Analysis
BPH With Symptomatic Lower Urinary Tract Symptoms
Recruiting
Learning Curve of Tri-lobar HoLEP Versus En-bloc HoLEP
Benign Prostatic Hyperplasia With Outflow Obstruction
RecruitingObservational study
Impact of Long-term Dutasteride Use on Perioperative Outcomes of HoLEP
Prostatic Hyperplasia, Benign
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Prostatic Hyperplasia and Prostatectomy, run by Centre Hospitalier de Gonesse at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in urinary symptoms after TURP, measured by the IPSS (time frame: From baseline (pre-surgery) to 1-3 months post-surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 May 2025.